United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide

Tubercle. 1987 Jun;68(2 Suppl):41-6. doi: 10.1016/0041-3879(87)90021-3.

Authors

L J Geiter¹, R J O'Brien, D L Combs, D E Snider Jr

Affiliation

¹ Division of Tuberculosis Control, Centers for Disease Control, Atlanta, Georgia 30333.

PMID: 3318048
DOI: 10.1016/0041-3879(87)90021-3

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Clinical Trials as Topic
Drug Combinations
Female
Humans
Isoniazid / adverse effects
Isoniazid / therapeutic use*
Male
Patient Compliance
Pyrazinamide / adverse effects
Pyrazinamide / therapeutic use*
Random Allocation
Rifampin / adverse effects
Rifampin / therapeutic use*
Tuberculosis, Pulmonary / drug therapy*

Substances

Drug Combinations
Pyrazinamide
Isoniazid
Rifampin